3/22/2010

Cascade Technologies has bought Los Angeles-based Spectral Molecular Imaging in a stock agreement. Spectral Molecular develops spectral-optical-imaging devices used to diagnose cancer in vivo as well as precancerous diseases.

Related Summaries